ArticleJournal of surgical case reports2025
A rare case of a mammary analog secretory carcinoma of the right submandibular gland.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salivary gland cancer is one of the most common malignant neoplasms of head and neck. Not only is it rare but its clinical course is also very heterogeneous. A 64-year-old woman was diagnosed with submandibular gland carcinoma. We performed an ultrasound examination and a magnetic resonance imaging of the head and neck, which revealed an oval expansive process in the right submandibular salivary gland, indicative of an aggressive neoplasm, such as adenocarcinoma. Surgical excision and histological examination were conducted reporting macroscopically a whitish nodular formation measuring 1.5 × 1 cm and microscopically positivity to cytokeratin 7 and mammaglobin, compatible with a mammary analog secretory carcinoma. No N positive since there is no clinical, instrumental, or laboratory evidence of the primary pathology. We just performed a surgical excision and accurate follow-up visits, and the patient has been free from disease for 2 years. Major efforts should be spent to establish the most adequate management and follow-up protocol visits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.